On 30 August 2017, the government released Life Sciences Industrial Strategy which sets out proposals to ensure the UK’s status as a world leader in life sciences.
The strategy was written by Professor Sir John Bell and aims to build on the UK’s strengths in life sciences to both improve health and wellbeing of its population and encourage economic growth.
The outlined strategy includes recommendations of the adoption of the Accelerated Access Review, to speed up the adoption of digital innovation and med tech, with support from the Academic Health Science Networks.
Responding to the launch of the Government’s life science strategy, Karen Livingstone, National Director of SBRI Healthcare – NHS England’s innovation investment engine said:
“We are delighted to see the government’s focus on the life science sector to drive accelerated uptake of innovations to address pressing challenges on healthcare problems. Having supported 200 companies to date, SBRI Healthcare is uniquely positioned to bridge the gap between the creation of new solutions and their adoption in the NHS. The focus in the Life Science Strategy on support for streamlining assessment, evaluation, enhancing manufacturing and translational research opportunities should improve the success of our innovative companies.”
Steve Feast, Managing Director of the Eastern AHSN, said:
“The launch today of the Life Science Strategy provides many opportunities for the Eastern region. The focus on creating life science clusters where industry and local partners can work together to create the right infrastructure, providing a ‘single front door’ to the UK for research and investment opportunities, builds upon the framework we are already working on.
The proposed hubs will each be aligned with an academic health science network footprint. Four to six “medtech centres of excellence” will be associated with the hubs, with each focusing on a different specific area of research, such as cardiac or digital health.
We are determined to make sure that Eastern is one of them. We are already working with our partners across Cambridge, especially Cambridge University Health Partners, and the wider region, to assure this happens for the benefit of citizens, industry and our communities.”
We were delighted to see our comment published in “Why Cambridge will be key to new Government’s life sciences strategy” article in Cambridge News. Read the full article.